Skip to main content

Advertisement

SpringerLink
Log in

Germline mutations in lung cancer and personalized medicine

  • Letter to the Editor
  • Published:
Familial Cancer Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Marafie MJ, Dashti M, Al-Mulla F (2017) Identification of a rare NBN gene mutation by whole exam sequencing in a lung cancer survivor from a large family with various types of cancer. Fam Cancer 16:389–394

    Article  PubMed  CAS  Google Scholar 

  2. Renieri A, Mencarelli MA, Cetta F et al (2014) Oligogenic germline mutations identified in early non smokers lung adenocarcinoma patients. Lung Cancer 85(2):168–174

    Article  PubMed  Google Scholar 

  3. Baldassari M, Fallerini C, Cetta F et al (2017) “Omic” approach in non-smokier female with lung squamous cell carcinoma pinpoints to gremlin susceptibility and personalized medicine. Cancer Res Treat. doi:10.4143/crt.2017.125 [Epub ahead of print]

    Article  Google Scholar 

  4. Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA Jr, Kinzler KW (2013) Cancer genome landscapes. Science 339:1546–1557

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  5. Cetta F (2015) FAP associated papillary thyroid carcinoma: a peculiar subtype of familial non medullary thyroid cancer. Patholog Res Int. 2015:309348

    PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The funding was provided by Regione Toscana - Istituto Toscano Tumori (ITT) (Project “Identification of genetic bases of individual predisposition to lung cancer in non-smokers”).

Author information

Authors and Affiliations

  1. IRCCS MultiMedica, Milan, Italy

    Francesco Cetta

  2. Medical Genetics, University of Siena, Viale Bracci, 2, 53100, Siena, Italy

    Alessandra Renieri & Elisa Frullanti

  3. Genetica Medica, Azienda Ospedaliera Universitaria Senese, Siena, Italy

    Alessandra Renieri

Authors
  1. Francesco Cetta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alessandra Renieri
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Elisa Frullanti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Elisa Frullanti.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cetta, F., Renieri, A. & Frullanti, E. Germline mutations in lung cancer and personalized medicine. Familial Cancer 17, 429–430 (2018). https://doi.org/10.1007/s10689-017-0044-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10689-017-0044-4

Search

Navigation